UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE

por Wolf, Myles
Publicado 2012

When There Will Never be a Randomized Controlled Trial

por Scialla, Julia J., Wolf, Myles
Publicado 2015

Renal proximal tubule cells: power and finesse

por Fuchs, Michaela A.A., Wolf, Myles
Publicado 2023

Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease

por Edmonston, Daniel, Isakova, Tamara, Wolf, Myles
Publicado 2023

Importance of Extra-Renal CYP24A1 Expression for Maintaining Mineral Homeostasis

por Shi, Melody, Grabner, Alexander, Wolf, Myles
Publicado 2021

Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose

por Schaefer, Benedikt, Zoller, Heinz, Wolf, Myles
Publicado 2021

FGF-23: More Than a Regulator of Renal Phosphate Handling?

por Jüppner, Harald, Wolf, Myles, Salusky, Isidro B
Publicado 2010

Echocardiography to Screen for Pulmonary Hypertension in CKD

por Edmonston, Daniel L., Rajagopal, Sudarshan, Wolf, Myles
Publicado 2020

Sildenafil and Kidney Function in Heart Failure with Preserved Ejection Fraction

por Edmonston, Daniel, Sparks, Matthew, Rajagopal, Sudarshan, Wolf, Myles
Publicado 2023

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome

por Glaspy, John A., Wolf, Myles, Strauss, William E.
Publicado 2021

Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials

por Wolf, Myles, Auerbach, Michael, Kalra, Philip A., Glaspy, John, Thomsen, Lars L., Bhandari, Sunil
Publicado 2020

Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparativ...

por Bhandari, Sunil, Kalra, Philip A, Berkowitz, Mario, Belo, Diogo, Thomsen, Lars L, Wolf, Myles
Publicado 2020

Targeting Vascular Calcification in Chronic Kidney Disease

por Nelson, Adam J., Raggi, Paolo, Wolf, Myles, Gold, Alexander M., Chertow, Glenn M., Roe, Matthew T.
Publicado 2020

Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside—a systematic review and meta‐analysis

por Schaefer, Benedikt, Tobiasch, Moritz, Viveiros, André, Tilg, Herbert, Kennedy, Nicholas A., Wolf, Myles, Zoller, Heinz
Publicado 2020

Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes

por Marebwa, Barbara K., Adams, Robert J., Magwood, Gayenell S., Kindy, Mark, Wilmskoetter, Janina, Wolf, Myles, Bonilha, Leonardo
Publicado 2018

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia

por Block, Geoffrey A, Rosenbaum, David P, Yan, Andrew, Greasley, Peter J, Chertow, Glenn M, Wolf, Myles
Publicado 2019

Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study

por Yokoyama, Keitaro, Fukagawa, Masafumi, Akiba, Takashi, Nakayama, Masaaki, Ito, Kyoko, Hanaki, Koji, Wolf, Myles, Hirakata, Hideki
Publicado 2019

Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised...

por Zoller, Heinz, Wolf, Myles, Blumenstein, Irina, Primas, Christian, Lindgren, Stefan, Thomsen, Lars L, Reinisch, Walter, Iqbal, Tariq
Publicado 2023

FGFR4 does not contribute to progression of chronic kidney disease

por Taylor, Ashlee, Yanucil, Christopher, Musgrove, John, Shi, Melody, Ide, Shintaro, Souma, Tomokazu, Faul, Christian, Wolf, Myles, Grabner, Alexander
Publicado 2019

Associations of FGF23 with 10-Year Change in eGFR and UACR and with Incident CKD in the CARDIA Cohort

por Sunderraj, Ashwin, Wong, Mandy, Gutiérrez, Orlando M., Wolf, Myles, Akhabue, Ehimare, Carnethon, Mercedes R., Yancy, Clyde W., Isakova, Tamara
Publicado 2023